Filed: 5/8/2025ACC: 0001104659-25-045686
📋 What this filing means
DECHENG CAPITAL LLC filed this quarterly 13F‑HR report disclosing 27 equity positions with a total reported market value of $356.49M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
27
Positions
$356.49M
Total AUM (reported)
71.36M
Total Shares
Allocation by class
COM$346.08M97.1%
SHS$6.97M2.0%
ADR$3.39M1.0%
WARRANTS$44.0K0.0%
Portfolio Concentration
Top 3$231.14M64.8%
4–10$77.21M21.7%
11–25$47.98M13.5%
Rest$152.0K0.0%
Top 3 weight
64.8%
Top 10 weight
86.5%
Voting Authority Distribution
Total shares with voting rights: 71.36M
Sole
Full voting authority
71.36M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole27
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings27
Rows:
CG ONCOLOGY INC
SOLEShares6.37M
TypeSH
Market value$156.04M
43.77%
Sole
6.37M
Shared
0.00
None
0.00
Nuvation Bio Inc.
SOLEShares25.95M
TypeSH
Market value$45.68M
12.81%
Sole
25.95M
Shared
0.00
None
0.00
AARDVARK THERAPEUTICS INC
SOLEShares3.92M
TypeSH
Market value$29.42M
8.25%
Sole
3.92M
Shared
0.00
None
0.00
Upstream Bio Inc.
SOLEShares3.29M
TypeSH
Market value$20.11M
5.64%
Sole
3.29M
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA CO NV
SOLEShares770K
TypeSH
Market value$15.76M
4.42%
Sole
770K
Shared
0.00
None
0.00
KRYSTAL BIOTECH INC
SOLEShares65K
TypeSH
Market value$11.72M
3.29%
Sole
65K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC(NSM)
SOLEShares226K
TypeSH
Market value$7.99M
2.24%
Sole
226K
Shared
0.00
None
0.00
MERUS NV
SOLEShares189.10K
TypeSH
Market value$7.96M
2.23%
Sole
189.10K
Shared
0.00
None
0.00
BeyondSpring Inc.
SOLEShares4.88M
TypeSH
Market value$6.97M
1.96%
Sole
4.88M
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares171.60K
TypeSH
Market value$6.70M
1.88%
Sole
171.60K
Shared
0.00
None
0.00
Lyell Immunopharma, Inc.
SOLEShares11.91M
TypeSH
Market value$6.41M
1.80%
Sole
11.91M
Shared
0.00
None
0.00
Arcus Biosciences, Inc
SOLEShares808.79K
TypeSH
Market value$6.35M
1.78%
Sole
808.79K
Shared
0.00
None
0.00
Aclaris Therapeutics, Inc.
SOLEShares4.04M
TypeSH
Market value$6.18M
1.73%
Sole
4.04M
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares177.96K
TypeSH
Market value$5.97M
1.67%
Sole
177.96K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares100K
TypeSH
Market value$4.02M
1.13%
Sole
100K
Shared
0.00
None
0.00
LEGEND BIOTECH CORP-ADR
SOLEShares100K
TypeSH
Market value$3.39M
0.95%
Sole
100K
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares50K
TypeSH
Market value$3.28M
0.92%
Sole
50K
Shared
0.00
None
0.00
Zentalis Pharmaceuticals Inc.
SOLEShares2.02M
TypeSH
Market value$3.21M
0.90%
Sole
2.02M
Shared
0.00
None
0.00
Aura Biosciences, Inc.
SOLEShares515.55K
TypeSH
Market value$3.02M
0.85%
Sole
515.55K
Shared
0.00
None
0.00
Biontech SE-ADR
SOLEShares20K
TypeSH
Market value$1.82M
0.51%
Sole
20K
Shared
0.00
None
0.00
Equillium Inc.
SOLEShares4.45M
TypeSH
Market value$1.74M
0.49%
Sole
4.45M
Shared
0.00
None
0.00
4D MOLECULAR THERAPEUTICS IN
SOLEShares335.51K
TypeSH
Market value$1.08M
0.30%
Sole
335.51K
Shared
0.00
None
0.00
Illumnia, Inc.
SOLEShares11.75K
TypeSH
Market value$932.2K
0.26%
Sole
11.75K
Shared
0.00
None
0.00
Pyxis Oncology, Inc (formerly Apexigen)
SOLEShares326.81K
TypeSH
Market value$320.2K
0.09%
Sole
326.81K
Shared
0.00
None
0.00
GRAIL INC
SOLEShares9.68K
TypeSH
Market value$247.3K
0.07%
Sole
9.68K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG ONCOLOGY INCSOLE | COM | 6.37M | SH | $156.04M 43.77% | 6.37M | 0.00 | 0.00 |
Nuvation Bio Inc.SOLE | COM | 25.95M | SH | $45.68M 12.81% | 25.95M | 0.00 | 0.00 |
AARDVARK THERAPEUTICS INCSOLE | COM | 3.92M | SH | $29.42M 8.25% | 3.92M | 0.00 | 0.00 |
Upstream Bio Inc.SOLE | COM | 3.29M | SH | $20.11M 5.64% | 3.29M | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA CO NVSOLE | COM | 770K | SH | $15.76M 4.42% | 770K | 0.00 | 0.00 |
KRYSTAL BIOTECH INCSOLE | COM | 65K | SH | $11.72M 3.29% | 65K | 0.00 | 0.00 |
REVOLUTION MEDICINES INC(NSM)SOLE | COM | 226K | SH | $7.99M 2.24% | 226K | 0.00 | 0.00 |
MERUS NVSOLE | COM | 189.10K | SH | $7.96M 2.23% | 189.10K | 0.00 | 0.00 |
BeyondSpring Inc.SOLE | SHS | 4.88M | SH | $6.97M 1.96% | 4.88M | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | COM | 171.60K | SH | $6.70M 1.88% | 171.60K | 0.00 | 0.00 |
Lyell Immunopharma, Inc.SOLE | COM | 11.91M | SH | $6.41M 1.80% | 11.91M | 0.00 | 0.00 |
Arcus Biosciences, IncSOLE | COM | 808.79K | SH | $6.35M 1.78% | 808.79K | 0.00 | 0.00 |
Aclaris Therapeutics, Inc.SOLE | COM | 4.04M | SH | $6.18M 1.73% | 4.04M | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 177.96K | SH | $5.97M 1.67% | 177.96K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM | 100K | SH | $4.02M 1.13% | 100K | 0.00 | 0.00 |
LEGEND BIOTECH CORP-ADRSOLE | ADR | 100K | SH | $3.39M 0.95% | 100K | 0.00 | 0.00 |
ARCELLX INCSOLE | COM | 50K | SH | $3.28M 0.92% | 50K | 0.00 | 0.00 |
Zentalis Pharmaceuticals Inc.SOLE | COM | 2.02M | SH | $3.21M 0.90% | 2.02M | 0.00 | 0.00 |
Aura Biosciences, Inc.SOLE | COM | 515.55K | SH | $3.02M 0.85% | 515.55K | 0.00 | 0.00 |
Biontech SE-ADRSOLE | COM | 20K | SH | $1.82M 0.51% | 20K | 0.00 | 0.00 |
Equillium Inc.SOLE | COM | 4.45M | SH | $1.74M 0.49% | 4.45M | 0.00 | 0.00 |
4D MOLECULAR THERAPEUTICS INSOLE | COM | 335.51K | SH | $1.08M 0.30% | 335.51K | 0.00 | 0.00 |
Illumnia, Inc.SOLE | COM | 11.75K | SH | $932.2K 0.26% | 11.75K | 0.00 | 0.00 |
Pyxis Oncology, Inc (formerly Apexigen)SOLE | COM | 326.81K | SH | $320.2K 0.09% | 326.81K | 0.00 | 0.00 |
GRAIL INCSOLE | COM | 9.68K | SH | $247.3K 0.07% | 9.68K | 0.00 | 0.00 |
Page 1 of 2